Immunome, Inc.
- IMNM
- NASDAQ
- Biotechnology
- Antibody-Drug Conjugates (ADC)
- Oncology Therapeutics
$16.77
Today +1.82%Quote Oct 19, 2026, 08:00 PM UTC
−30.04%over the last month
Max drawdown −36.0%From 1-month high −34.9%3 months −26.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Immunome
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
247
Founded
2006
Market value
$1.98B
Quote Oct 19
Floor
$15.29
8.8% below price
Resistance
$17.54
4.6% above price
Price vs analyst targets
13 analysts
Lowest target
$24.00Highest target
$37.00
$24.00Highest target
$37.00
- Price $16.77
- Average target $33.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 97% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IMNMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free